Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
| 4 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
| 12 | 0 | 0 | 2.11 | 2.11 | 2.11 | 0 | 0 | CS |
| 26 | -1.55 | -42.349726776 | 3.66 | 4.4 | 1.69 | 49489 | 2.73704817 | CS |
| 52 | -2.97 | -58.4645669291 | 5.08 | 7.42 | 1.61 | 69739 | 3.28184491 | CS |
| 156 | -9.468 | -81.7757816549 | 11.578 | 11.578 | 1.01 | 184314 | 4.43830919 | CS |
| 260 | -9.89 | -82.4166666667 | 12 | 49.4 | 1.01 | 573560 | 23.62700944 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
